JPMorgan BetaBuilders Europe ETF BBEU

JPMorgan BetaBuilders Europe ETF tracks the performance of stocks traded on the primary exchanges in developed countries across Europe. Passively managed by JP Morgan, this ETF was established in 2018.

The JPMorgan BetaBuilders Europe ETF fund’s primary goal is to provide investment results that mimic the performance of the Morningstar Developed Europe Target Market Exposure Index. This index seeks to provide access to 85% of the equity float-adjusted market capitalisation companies in the developed Europe markets. The base currency of this fund is USD.

Listed on the Cboe BZX stock exchange, stock for the JPMorgan BetaBuilders Europe ETF is listed under the ticker BBEU. As of 2nd September 2022, this ETF had total net assets of $2.7bn and held 538 investments. This fund includes stock in a broad range of sectors, including financials, healthcare, industrials and consumer staples. This fund is considered to be diversified. As of 2nd September 2022, some of the fund’s top holdings included Nestle SA, Roche Holding AG, Shell PLC, Novartis AG, ASML Holding NV, Astra Zeneca PLC, LVMH Moet Hennessy Louis, Novo Nordisk A/S, HSBC Holdings PLC and Total Energies SE.

For price updates on BBEU and other stocks, make sure to add them to your eToro watchlist.